Clinical Trial Update: BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of BMS-582664 with Erbitux in patients with advanced gastrointestinal malignancies, including colorectal cancer. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BMS-582664
• ERBITUX (cetuximab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED